ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Teorías del Long COVID entrelazadas para explicar la etiopatogenia / Intertwined long COVID theories to explain its etiopathogenesis

Luis Del Carpio-Orantes, Andrés Aguilar-Silva

Resumen


Resumen

En este editorial se enumeran las principales teorías actuales sobre el long COVID, como la teoría de la persistencia viral y la de la inmunotrombosis asociada a desregulación del sistema inmune; se discute también su interrelación, que explica la etiopatogenia y fisiopatología de este nuevo síndrome que aqueja a los sobrevivientes de COVID-19; se discute además un nexo entre la persistencia viral y la formación de microtrombos amiloides con base en la hipótesis de que la proteína spike condiciona amiloidogénesis, lo cual condicionará daño orgánico crónico que caracterizará al long COVID.

 

Abstract

This editorial lists the main current theories on long COVID, such as the theory of viral persistence and the one of immunothrombosis associated with deregulation of the immune system; it is discussed as well their interrelation, which finally explains the etiopathogenesis and physiopathology of this new syndrome that afflicts the survivors of COVID-19; it is also discussed the link between viral persistence with the formation of amyloid microthrombi based on the hypothesis that the spike protein conditions amyloidogenesis, conditioning organic chronic damage that will characterize long COVID.


Palabras clave


COVID 19; Disbiosis; Trombosis; Amiloide / COVID-19; Dysbiosis; Thrombosis; Amyloid

Texto completo:

PDF

Referencias


 

 

Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Muñoz P, et al.; Gregorio Marañon Microbiology ID COVID 19 Study Group. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22(1):211. doi: 10.1186/s12879-022-07153-4.

 

Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172. doi: 10.1186/s12933-021-01359-7.

 

Nyström S, Hammarström P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J Am Chem Soc. 2022;144(20):8945-50. doi: 10.1021/jacs.2c03925.

 

Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585): 1122-7. doi: 10.1126/science.abm8108.

 

Arthur JM, Forrest JC, Boehme KW, Kennedy JL, Owens S, Herzog C, et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16(9):e0257016. doi: 10.1371/journal.pone.0257016.

 

Algaadi SA. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Infection. 2022;50(2):289-93. doi: 10.1007/s15010-021-01714-6 7. Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6):763. doi: 10.3390/ pathogens10060763.

 

Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive MC, Dutta P, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight. 2021;6(20):e152346. doi: 10.1172/ jci.insight.152346.

 

Papadopoulou M, Bakola E, Papapostolou A, Stefanou MI, Gaga M, Zouvelou V, et al. Autonomic dysfunction in long-COVID syndrome: a neurophysiological and neurosonology study. J Neurol. 2022;269(9):4611-2. doi: 10.1007/s00415-022-11172-1.

 

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023. doi: 10.1038/s41579-022-00846-2.


Enlaces refback

  • No hay ningún enlace refback.